Taiwan's Nobel equivalent, the Tang Prize, honors pioneers of cancer immunotherapy (opens original article in a new tab)

The 2026 Tang Prize in Biopharmaceutical Science was awarded to three scientists for their pioneering work in cancer immunotherapy, recognizing their development of TIL and CAR-T therapies that use patients' immune cells to fight cancer.

• 2026 Tang Prize in Biopharmaceutical Science awarded to three scientists for pioneering cancer immunotherapy work
• TIL and CAR-T therapies were recognized for revolutionizing cancer treatment by using patients' immune cells
• Laureates include Steven A. Rosenberg, Michel Sadelain, and Carl H. June from the U.S. and France/Canada